Trial Profile
PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 14 Sep 2021
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms PREVENTIHS
- 09 Sep 2021 Status changed from recruiting to suspended.
- 10 Oct 2017 Planned primary completion date changed from 1 Aug 2015 to 1 Dec 2020.
- 10 Oct 2017 Status changed from suspended to recruiting.